Results 141 to 150 of about 4,574,160 (318)

The Benefit of Doubting [PDF]

ACS Sensors, 2020
openaire   +3 more sources

Minutes: Benefits Advisory Committee: July 18, 2013

, 2013
University of Minnesota: Benefits Advisory Committee. (2013). Minutes: Benefits Advisory Committee: July 18, 2013.
University of Minnesota: Benefits Advisory Committee
core  

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

Molecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim, Maryam Aslam, Elouise Torruella, Alphons Sony, Asif Rahman, Simira Smith, Columba de la Parra, Moira Sauane   +7 more
wiley   +1 more source

Minutes: Benefits Advisory Committee: March 12, 2015

, 2015
University of Minnesota. Benefits Advisory Committee. (2015). Minutes: Benefits Advisory Committee: March 12, 2015.
University of Minnesota. Benefits Advisory Committee
core  

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source

88 The Changing Landscape of Stroke Prevention in Subclinical Atrial Fibrillation and a Potential Path Forward in the Veteran Population: A Population Health Anticoagulation Stewardship Initiative

Research and Practice in Thrombosis and Haemostasis
Arthur Allen, David Parra, Jeffery Kibert   +2 more
doaj   +1 more source

Minutes: Benefits Advisory Committee: May 21, 2015

, 2015
University of Minnesota. Benefits Advisory Committee. (2015). Minutes: Benefits Advisory Committee: May 21, 2015.
University of Minnesota. Benefits Advisory Committee
core  

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Corrigendum: Potential and unrealized future possibilities of browntop millet in the food sector

Frontiers in Sustainable Food Systems, 2023
Shivani Singh, Sukhneet Suri, Ranjana Singh   +2 more
doaj   +1 more source

Functional Electrical Stimulation and Stroke Rehabilitation Research: The Critical Role of Sham Control Groups. [PDF]

Physiother Res Int
Ali-Hassan Y, Musselman KE, Wang RH.
europepmc   +1 more source